4002.SR · Mouwasat (Healthcare)

Stock detail · ranked as of 2026-10-27 · model linear v20261029-39712336 · trained through 2026-07-28
Peer percentile
58
rank 49 of 114
Quintile
Q3
over the next ~3 months
Past 3m range (q10 / median / q90)
-17% / -2% / +18%
historical, last 5 years
Model holdout IC
+0.048
edge confirmed · t 2.08

Price vs equal-weight universe (rebased 100 at the ranking date)

Why it ranks here (top drivers)

Its own past 3-month returns (last 5 years)

Ranking history for this stock

As ofModelHorizonPercentileQuintileRank
2026-10-27linear v20261029-3971233663 58Q349

Realised outcomes of every ranking date are tracked on Model Health → Live tracking.

Fundamentals & dividends data staleness: 0 days

SnapshotFYEBV/shareTotal assetsEquityROEROADiv yieldDebt/Equity
2026-10-292025-12-31 — 5,986,267,405 3,778,003,985 22.6% 9.2% 3.82% 0.29
2026-10-292024-12-31 — 5,402,799,743 3,568,337,934 22.6% 9.2% 3.82% 0.29
2026-10-292023-12-31 — 4,964,546,597 3,277,056,004 22.6% 9.2% 3.82% 0.29
2026-10-292022-12-31 — 4,661,581,603 2,922,846,424 22.6% 9.2% 3.82% 0.29
2026-10-29— 19.83 — — 22.6% 9.2% 3.82% 0.29
2026-10-282025-12-31 — 5,986,267,405 3,778,003,985 22.6% 9.2% 3.82% 0.29
2026-10-282024-12-31 — 5,402,799,743 3,568,337,934 22.6% 9.2% 3.82% 0.29
2026-10-282022-12-31 — 4,661,581,603 2,922,846,424 22.6% 9.2% 3.82% 0.29

Fundamentals are point-in-time as-of snapshots; annual figures lag fiscal-year-end by the configured +90 days.

Read-only snapshot · published 2026-10-29 22:07 (Riyadh)